566 related articles for article (PubMed ID: 16087391)
1. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
[TBL] [Abstract][Full Text] [Related]
2. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
[TBL] [Abstract][Full Text] [Related]
3. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
4. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of 10-aza-substituted benzo[a]pyrene by cytochrome P450 1A2 in human liver microsomes.
Yamada K; Suzuki T; Hakura A; Mizutani T; Saeki K
Mutat Res; 2004 Feb; 557(2):159-65. PubMed ID: 14729370
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K
Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
Saito J; Sakai Y; Nagase H
Mutat Res; 2006 Oct; 609(1):68-73. PubMed ID: 16884943
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different in vitro mutation assays used for the investigation of cytochrome P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons.
Kappers WA; van Och FM; de Groene EM; Horbach GJ
Mutat Res; 2000 Mar; 466(2):143-59. PubMed ID: 10727902
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide supports human and rat cytochrome P450 1A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase.
Anari MR; Josephy PD; Henry T; O'Brien PJ
Chem Res Toxicol; 1997 May; 10(5):582-8. PubMed ID: 9168257
[TBL] [Abstract][Full Text] [Related]
12. Metabolism-dependent mutagenicity of a compound containing a piperazinyl indazole motif: Role of a novel p450-mediated metabolic reaction involving a putative oxaziridine intermediate.
Chen H; Murray J; Kornberg B; Dethloff L; Rock D; Nikam S; Mutlib AE
Chem Res Toxicol; 2006 Oct; 19(10):1341-50. PubMed ID: 17040103
[TBL] [Abstract][Full Text] [Related]
13. Genotoxic activation of 2-phenylbenzotriazole-type compounds by human cytochrome P4501A1 and N-acetyltransferase expressed in Salmonella typhimurium umu strains.
Oda Y; Watanabe T; Terao Y; Nukaya H; Wakabayashi K
Mutat Res; 2008 Jun; 654(1):52-7. PubMed ID: 18562244
[TBL] [Abstract][Full Text] [Related]
14. In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice.
Yamada K; Suzuki T; Kohara A; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2004 Apr; 559(1-2):83-95. PubMed ID: 15066577
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108.
Miyazaki M; Sugawara E; Yoshimura T; Yamazaki H; Kamataki T
Mutat Res; 2005 Mar; 581(1-2):165-71. PubMed ID: 15725615
[TBL] [Abstract][Full Text] [Related]
16. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
[TBL] [Abstract][Full Text] [Related]
17. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens.
Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T
Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838
[TBL] [Abstract][Full Text] [Related]
18. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers.
Pavanello S; Simioli P; Lupi S; Gregorio P; Clonfero E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):998-1003. PubMed ID: 12376499
[TBL] [Abstract][Full Text] [Related]
19. In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation.
Hashizume T; Yoshitomi S; Asahi S; Matsumura S; Chatani F; Oda H
Mutat Res; 2009; 677(1-2):1-7. PubMed ID: 19501186
[TBL] [Abstract][Full Text] [Related]
20. In vitro mutagenicity and metabolism of the cycloaliphatic epoxy Cyracure UVR 6105.
Kostoryz EL; Smith RE; Glaros AG; Chappelow CC; Eick JD
Mutat Res; 2004 Sep; 563(1):25-34. PubMed ID: 15324746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
